Visualisation and quantification of rates of atrophy in Alzheimer's disease

Lancet

Volumn 348, Issue 9020, 1996, Pages 94-97

  Fox, Nick C ^a,b   Freeborough, Peter A ^a,b   Rossor, Martin N ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0030582181     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)05228-2     Document Type: Article

References (26)

1. 1 DeCarli C, Kaye JA, Horwitz B, Rapoport SI. Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology 1990; 40: 872-83.
2. 2 Jobst KA, Smith AD, Szatmari M, et al. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992; 340: 1179-83.
3. 3 Davis PC, Gearing M, Gray L, et al. The CERAD experience, part VIII: neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology 1995; 45: 178-79.
4. 4 Rusinek H, de Leon MJ, George AE, et al. Alzheimer's disease: measuring loss of cerebral gray matter with MR imaging. Radiology 1991; 178: 109-14.
5. 5 Davis PC, Gray L, Albert M, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part III - reliability of a standardized MRI evaluation of Alzheimer's disease. Neurology 1992; 42: 1676-80.
6. 6 Convit A, de Leon MJ, Golomb J, et al. Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatric Quart 1993; 64: 371-87.
7. 7 Murphy DGM, DeCarli C, Schapiro MB, Rapoport SI, Horwitz B. Age-related differences in volumes of subcortical nuclei, brain matter and cerebospinal fluid in healthy men as measured with magnetic resonance imaging. Arch Neurol 1992; 49: 839-45.
8. 8 DeCarli C, Murphy DG, McIntosh AR, Teichberg D, Schapiro MB, Horwitz B. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res 1995; 57: 119-30.
9. 9 Convit A, de Leon MJ, Tarshish C, et al. Hippocampal volume losses in minimally impaired elderly. Lancet 1995; 345: 266.
10. 10 Fox NC, Hartikainen P, Rossor MN. Alzheimer's disease and structural imaging: CT and MRI. In: Dawburn D, Allen SJ, eds. Neurobiology of Alzheimer's disease. Oxford: BIOS Scientific Publishers, 1995: 269-88.
11. 11 Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993; 50: 949-54.
12. 12 Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR 1994; 15: 927-37.
13. 13 Ikeda M, Tanabe H, Nakagawa Y, et al. MRI-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer's disease. Neuroradiology 1994; 36: 7-10.
14. 14 de Leon MJ, George AE, Reisburg B, et al. Alzheimer's disease: longitudinal CT studies of ventricular change. AJR 1989; 152: 1257-62.
15. 15 Jobst KA, Smith AD, Szatmari M, et al. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet 1994; 343: 829-30.
16. 16 Fox NC, Warrington EK, Stevens J, Rossor MN. Atrophy of the hippocampal formation in early familial Alzheimer's disease: a longitudinal MRI study of at risk members of a family with an amyloid precursor protein 717 val->gly mutation. Ann N Y Acad Sci 1996; 777: 226-32.
17. 17 Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 1992; 16: 620-33.
18. 18 Hajnal JV, Saeed N, Soar EJ, Oatridge A, Young IR, Bydder GM. A registration and interpolation procedure for subvoxel matching of serially acquired MR images. J Comput Assist Tomogr 1995; 19: 289-96.
19. 19 Hajnal JV, Saeed N, Oatridge A, Williams EJ, Young IR, Bydder GM. Detection of subtle brain changes using subvoxel registration and subtraction of serial MR images. J Comput Assist Tomogr 1995; 19: 677-91.
20. 20 Fox NC, Freeborough PA, Rossor MN. Visualising and quantifying rates of atrophy in Alzheimer's disease from registered serial 3D MRI of the brain. Proc Int Soc Magnetic Resonance Med 1996; 1: 234.
21. 21 Freeborough PA, Fox NC. Comparison of methods of registration of serial 3D MR brain scans: applications in Alzheimer's disease and related disorders. Proc Int Soc Magnetic Resonance Med 1996; 1: 34.
22. 22 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-44.
23. 23 Folstein M, Folstein S, McHughs P. The "Mini mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
24. 24 Freeborough PA, Fox NC, Kitney RI. Accurate segmentation of 3D brain scans: interactive software and algorithms. Proc Eurographics UK Conf 1996; 2: 261-71.
25. 25 Newman SK, Warrington EK, Kennedy AM, Rossor MN. The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. J Neurol Neurosurg Psychiatry 1994; 57: 967-72.
26. 26 Kennedy AM, Frackowiak RSJ, Newman SK, et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 1995; 186: 17-20.